Intracellular transport of acid β-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation)

• Published in: The Journal of pathology 1999-08, Vol.188 (4), p.407-414
• Main Authors: Zimmer, Klaus-Peter, le Coutre, Philipp, Aerts, Hans M. F. G., Harzer, Klaus, Fukuda, Minoru, O'Brien, John S., Naim, Hassan Y.
• Format: Article
• Language: English
• Subjects: acid β-glucosidase; Antigens, CD - metabolism; Biological and medical sciences; Biological Transport - genetics; cathepsin D; Cathepsin D - metabolism; Endoplasmic Reticulum - metabolism; Enzyme Activators - metabolism; Errors of metabolism; Gaucher Disease - genetics; Gaucher Disease - metabolism; Gaucher's disease; Glucosylceramidase - genetics; Glucosylceramidase - metabolism; Glycoproteins - metabolism; Humans; Infant; intracellular transport; LAMP-1; LAMP-2; Lipids (lysosomal enzyme disorders, storage diseases); Lysosomal Membrane Proteins; Lysosomes - enzymology; Male; Medical sciences; Membrane Glycoproteins - metabolism; Metabolic diseases; Microscopy, Immunoelectron; Mutation; saposin C; Saposins; thin frozen section and immunogold technique
• ISSN: 0022-3417; 1096-9896
• DOI: 10.1002/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z

Gaucher's disease (GD) is caused by an inherited deficiency of acid β‐glucosidase with storage of glucosylceramides in the lysosomes of macrophages. This study identifies a G202R mutation in the acid β‐glucosidase gene in an infant with severe neuronopathic (type 2) GD and only slightly reduced acid β‐glucosidase activity. Western blot analysis, pulse chase experiments, and the thin frozen section immunogold method were used to analyse the implications of this mutation on the pathogenesis, clinical heterogeneity and diagnostic evaluation of GD. The results show that acid β‐glucosidase persists in the patient's fibroblasts as a mannose‐rich polypeptide in the endoplasmic reticulum and is not transported to the lysosomes. By contrast, high expression of the lysosome‐associated membrane proteins LAMP‐1 and LAMP‐2, saposin C, and cathepsin D was observed in the patient's lysosomes. Immunogold labelling of the integral membrane proteins LAMP‐1 and LAMP‐2 increases significantly at the cell surface of Kupffer cells and fibroblasts as well as at the apical membrane of hepatocytes. In addition, LAMP‐1 and LAMP‐2 associate with the bilayer of stored glucosylceramide. It is concluded that defective intracellular transport of mutant acid β‐glucosidase from the endoplasmic reticulum to lysosomes leads to a more severe clinical phenotype than the residual enzyme activity may indicate. Furthermore, the detection of LAMP in the tubular bundles of undigested glucosylceramides, as well as their increased concentration at the surfaces of the affected cells, suggests that these proteins play a role in the storage or removal of substrate in GD. Intracellular targeting of acid β‐glucosidase and LAMP contributes to the broad phenotypic heterogeneity of GD. Copyright © 1999 John Wiley & Sons, Ltd.